ADM (ADM) Q3 2026 Earnings Call Transcript

ADM reported third-quarter adjusted EPS of $1.77, up 92% year over year, and total segment operating profit of $1.4 billion, up 64%, supported by favorable North American biofuels margins and execution. The company raised full-year 2026 adjusted EPS guidance to $5.50–$5.80 from $5.15–$5.60 and increased its expected 45Z net benefit to approximately $350 million from $250 million. ADM also lowered 2026 capital expenditure guidance to $1.2–$1.3 billion and repurchased $360 million of shares; pressure in liquid sweeteners, Nutrition downtime, and South American crush margins remained offsets.

Analysis

The key question is earnings durability, not the size of the beat. ADM’s incremental profit is unusually exposed to U.S. biofuel economics: blending mandates and energy prices support soybean-oil demand, improving crush economics and utilization across an integrated footprint. That can create real operating leverage, but it also makes the earnings run-rate vulnerable to policy changes, weaker energy prices, or a reversal in crush spreads. South America’s delayed policy implementation is a reminder that regional capacity does not earn the same returns at the same time.

The raised outlook is not a clean baseline for extrapolating into 2027. It includes a larger expected 45Z contribution, while Q3 also included a one-time insurance reserve release; management expects some mark-to-market reversals, but does not forecast new impacts. Separately, continued sweetener pressure and a plant ramp-up leave Nutrition less uniformly strong than the headline segment growth suggests. Lower CapEx may reflect project sequencing and return discipline, not necessarily a durable reduction in reinvestment needs.

Contrarian view: investors may be too quick to treat biofuel-supported crush margins as either fully permanent or already peaked. Management’s favorable 2027 outlook is conditional, and should be tested against realized margins and policy implementation. Precision fermentation and carbon-removal initiatives are options on long-term growth, not near-term earnings offsets; verify customer-backed investment and returns before assigning material value.

Key Decisions for Investors

• Maintain or add only a modest tactical long in ADM, preferably on weakness rather than chasing the earnings reaction. The near-term catalyst is delivery against the raised FY26 range; the thesis is operating leverage to U.S. biofuel demand, not a near-term rerating from precision fermentation.
• For the next 1–3 months, track crush and ethanol margins, realized 45Z benefit, and the Q4 mark-to-market reversal. Reassess the long thesis if management lowers the $5.50–$5.80 adjusted EPS range or if reported biofuel margins materially weaken.
• Do not annualize Q3 earnings: separate the one-time insurance release and commodity mark-to-market effects from recurring segment performance, and treat the 45Z estimate as policy-sensitive rather than a guaranteed run-rate.
• Watch policy implementation and trade flows as 6–18 month risks: weaker U.S. blending obligations, delayed biofuel rules in Brazil, or China soybean purchases falling short of assumptions would pressure the margin outlook. The thesis is falsified by sustained deterioration in crush economics or a downward guidance revision.